Next Article in Journal
Glucosamine-Induced Autophagy through AMPK–mTOR Pathway Attenuates Lipofuscin-Like Autofluorescence in Human Retinal Pigment Epithelial Cells In Vitro
Next Article in Special Issue
Interferon Crevicular Fluid Profile and Correlation with Periodontal Disease and Wound Healing: A Systemic Review of Recent Data
Previous Article in Journal
The DNA Methylome and Association of Differentially Methylated Regions with Differential Gene Expression during Heat Stress in Brassica rapa
Previous Article in Special Issue
Instillation of Sericin Enhances Corneal Wound Healing through the ERK Pathway in Rat Debrided Corneal Epithelium
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 19
Issue 5
10.3390/ijms19051415
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions

by
Bhavani S. Kowtharapu
1,*,
Ruby Kala Prakasam
1,
Radovan Murín
2,
Dirk Koczan
3,
Thomas Stahnke
1,
Andreas Wree
4,
Anselm G. M. Jünemann
1 and
Oliver Stachs
1
1
Department of Ophthalmology, Rostock University Medical Center, 18057 Rostock, Germany
2
Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia
3
Institute for Immunology, Rostock University Medical Center, 18057 Rostock, Germany
4
Institute for Anatomy, Rostock University Medical Center, 18057 Rostock, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(5), 1415; https://doi.org/10.3390/ijms19051415
Submission received: 12 April 2018 / Revised: 2 May 2018 / Accepted: 7 May 2018 / Published: 9 May 2018
(This article belongs to the Special Issue New Innovations in Wound Healing and Repair)
Browse Figures
Versions Notes

Abstract

:
In the cornea, healing of the wounded avascular surface is an intricate process comprising the involvement of epithelial, stromal and neuronal cell interactions. These interactions result to the release of various growth factors that play prominent roles during corneal wound healing response. Bone morphogenetic proteins (BMPs) are unique multi-functional potent growth factors of the transforming growth factor-beta (TGF-β) superfamily. Treatment of corneal epithelial cells with substance P and nerve growth factor resulted to an increase in the expression of BMP7 mRNA. Since BMP7 is known to modulate the process of corneal wound healing, in this present study, we investigated the influence of exogenous rhBMP7 on human corneal epithelial cell and stromal cell (SFs) function. To obtain a high-fidelity expression profiling of activated biomarkers and pathways, transcriptome-wide gene-level expression profiling of epithelial cells in the presence of BMP7 was performed. Gene ontology analysis shows BMP7 stimulation activated TGF-β signaling and cell cycle pathways, whereas biological processes related to cell cycle, microtubule and intermediate filament cytoskeleton organization were significantly impacted in corneal epithelial cells. Scratch wound healing assay showed increased motility and migration of BMP7 treated epithelial cells. BMP7 stimulation studies show activation of MAPK cascade proteins in epithelial cells and SFs. Similarly, a difference in the expression of claudin, Zink finger E-box-binding homeobox 1 was observed along with phosphorylation levels of cofilin in epithelial cells. Stimulation of SFs with BMP7 activated them with increased expression of α-smooth muscle actin. In addition, an elevated phosphorylation of epidermal growth factor receptor following BMP7 stimulation was also observed both in corneal epithelial cells and SFs. Based on our transcriptome analysis data on epithelial cells and the results obtained in SFs, we conclude that BMP7 contributes to epithelial-to-mesenchymal transition-like responses and plays a role equivalent to TGF-β in the course of corneal wound healing.

1. Introduction

In the cornea, endogenously produced growth factors play a crucial role in modulating the functions of corneal epithelial and stromal cells [1,2,3]. A multitude of growth factors including epidermal growth factor (EGF), transforming growth factor-alpha and beta (TGF-α and -β), keratinocyte growth factor, fibroblast growth factor, hepatocyte growth factor, insulin-like growth factor, platelet-derived growth factor along with inflammatory cytokines such as interleukin (IL)-1, IL-6 and tumor necrosis factor (TNF)-α play important roles by influencing the migration, mitosis, proliferation and differentiation of corneal cells [4,5]. In conjunction, neurotrophic factors produced in the cornea elevate expression levels of vital growth factors and alter the corneal cell functions [6,7,8]. Similarly, corneal epithelial cell-derived growth factors also influence the function of corneal stromal cells [2].
TGF-β superfamily is one of the most important groups of cytokines involved in orchestrating the course of various essential cellular functions in the cornea [9,10]. The bone morphogenetic proteins (BMPs) are secreted, multifunctional, potent growth factors constituting the largest subgroup of the TGF-β superfamily [11]. The cellular responses stimulated by BMPs are mediated by two types of activated transmembrane serine/threonine kinase receptors, type I (BMPR-IA and BMPR-IB) and type II (BMPR-II) [12]. Subsequent signaling events are mediated by both, Smad-dependent and -independent pathways [13]. During BMP stimulated cellular signal transduction, the specifically triggered signaling pathway is reliant on the cellular activity, extracellular factors and crosstalk with other signaling cascades [14]. In general, BMP-mediated signaling is controlled intracellularly by methylation and inhibitory Smads and extracellularly by its antagonists [15,16]. BMPs are extensively expressed in the course of mammalian development and exert effect on numerous cellular functions with a wide range of biological activities on various cell types including development, morphogenesis, proliferation and extracellular matrix synthesis [17]. Throughout the development of the eye, BMP signaling has been shown to be pivotal in the regulation of early eye development [18], differentiation of retina [19], development of lens [20] and ciliary body [21]. Various BMPs (BMP2, -3, -4, -5 and -7) and their receptors have been shown to be expressed in the corneal epithelium and stroma [22,23]. BMPs, by inducing the expression of extracellular matrix components, also facilitate migration of cells during wound healing [24].
After injury, intracellular signaling cross-talk, due to the release of different growth factors at the wound site, collectively culminates to cell motility, migration and wound closure [24]. Likewise, in the course of growth factor-mediated signaling, cross-communication between different signaling pathways is eminent in different cell types which play an essential role in mediating activation of various signaling cascades and cellular functions [16,25]. For example, G-protein-coupled receptors and cAMP are known to use epidermal growth factor receptor (EGFR) to trigger downstream mitogenic signaling events [26,27,28]. In the same way, BMP7 also regulates the activation of EGFR [29]. In the cornea, EGFR transactivation through non-EGF ligands influences the differentiation of corneal stromal cells [30] as well as epithelial wound healing [31,32].
Of all the BMP family members, BMP7 functions as an indispensable signaling molecule during mammalian eye development [33]. Overexpression of BMP7 has been shown to effectively modulate cell proliferation [34], Smad signaling in mouse [35] and rabbit corneas [36]. Similar to TGF-β [37], BMP7 is also known to be involved in the progression of EMT [38] along with its role in wound healing [35,39]. Furthermore, in our previous study, we also observed differences in the expression of BMP7 during corneal epithelial and neuronal interactions [40]. Since BMP7 plays an important role as a trophic factor [41] as well as in sustaining the epithelial phenotype [42] and modulating the function of corneal cells, the present study is designed to investigate the influence of exogenous recombinant human BMP7 (rhBMP7) on corneal epithelial cells and corneal stromal fibroblasts (SFs) functions in vitro. Furthermore, we also performed transcriptome-wide gene-level expression profiling of corneal epithelial cells in the presence of rhBMP7 to obtain a high-fidelity expression profiling of activated biomarkers and pathways.

2. Results

2.1. Elevation of BMP7 mRNA Expression after Treatment of Telomerase-Immortalized Human Corneal Epithelial (hTCEpi) Cells with Substance P (SP) and Nerve Growth Factor (NGF)

In the presence of neuropeptides SP and NGF, hTCEpi cells showed enhanced expression of BMP7 mRNA. Corneal epithelial cells, after 24 h of treatment with SP, showed 6.2-fold increase in the expression of BMP7 mRNA whereas treatment with NGF also resulted to 3.8-fold increased expression compared to the control untreated cells (Figure 1).

2.2. Gene Expression Profiling (GEP) of Recombinant Human BMP7 (rhBMP7) Stimulated hTCEpi Cells

Since treatment of SP and NGF enhanced the expression levels of BMP7 mRNA, we also studied the consequences of BMP7 on epithelial cell function by performing GEP of BMP7 stimulated epithelial cells. After treatment of hTCEpi cells with BMP7 for 24 h, cells were collected to isolate RNA and gene level differential expression analysis was performed using Clariom™ S arrays. Of the 21,448 genes analyzed, 2026 genes were found to be differentially expressed (1257 genes were up-regulated and 769 genes were down-regulated) after treatment of hTCEpi cells in the presence of BMP7 comparing to the control untreated cells (Figure 2).
Graphical representation of the distribution of differentially expressed genes is shown in Figure S1. An up-regulation of SMAD family member 6 (SMAD6), a natural inhibitor of BMPs signaling [43], in BMP7 treated epithelial cells (56-fold) serves as a positive control in our present study. Gene ontology analysis confirms differential expression of 11 out of 18 genes that are responsive to BMP stimulus in this present study: up-regulation of desmoglein 4 (DSG4), SMAD6, SMAD7, SMAD9, inhibitor of DNA-binding 1 (ID1), BMP2, distal-less homeobox 5 (DLX5), proprotein convertase subtilisin/kexin Type 6 (PCSK6), ADAM metallopeptidase with thrombospondin type 1 motif 7 (ADAMTS7), SKI-like proto-oncogene (SKIL); and down-regulation of twisted gastrulation BMP signaling modulator 1 (TWSG1). The most significantly impacted pathways, after stimulation of corneal epithelial cells with BMP7, were TGF-β signaling pathway and cell cycle (with p < 0.05) (Table 1).
Biological processes related to cell cycle and its regulation, microtubule and intermediate filament cytoskeleton organization and tissue development are most significantly impacted along with other processes after BMP7 stimulation (Table 2) (analyzed using Advaita Bio’s iPathwayGuide; http://www.advaitabio.com/ipathwayguide).
A complete list of genes with most profound differential expressions after BMP7 treatment compared to control in hTCEpi cells, with a cutoff of Anova p-value 0.001 and fold change 8 or −8, are given in Table 3.

2.3. qRT-PCR Validation of the Transcriptome Analysis Data

To further validate the transcriptome analysis data obtained after treatment of hTCEpi cells with BMP7, we performed qRT-PCR of some selected up-regulated transcripts using RNA isolated from BMP7 treated hTCEpi cells. Differential expression of various cytoskeletal proteins, ID proteins and metabolic enzymes were analyzed and confirmed. Microarray data of ID1 and ID2 shows an up-regulation of 37.6-fold and 8.3-fold, whereas qRT-PCR shows 15.7-fold and 7.7-fold. (Figure 3A). Of the analyzed cytoskeletal proteins DSG4 and epsin 3 (EPN3), microarray data show an up-regulation of 43.5-fold, 13.6-fold, whereas qRT-PCR data show an up-regulation of 43-fold and 5-fold (Figure 3B). Similarly, of the analyzed metabolic enzymes lysyl oxidase (LOX), dual specificity phosphatase 14 (DUSP14), transglutaminase 5 (TGM5), crystallin alpha B (CRYAB) and ATPase, Na+/K+ transporting, beta 1 (ATP1B1), microarray data show an up-regulation of 20-fold, 10-fold, 96-fold, 28-fold and 12.8-fold, whereas qRT-PCR data show 15-fold, 15.6-fold, 10-fold, 4.3-fold and 2.3-fold (Figure 3C).

2.4. Influence of rhBMP7 on the Migration of hTCEpi Cells

Based on our GEP data, we further studied the effect of BMP7 on epithelial cell motility and migration by performing a scratch wound healing assay. We observed an enhanced motility and migration of epithelial cells in the presence of BMP7. During scratch assay, BMP7 treated corneal epithelial cells filled the scratch area much faster than untreated control cells. Cell migration was represented as number of cells filling the central gap area after making the scratch. We observed a significant increase in the number of migrating cells after BMP7 treatment in conditions, 10 and 24 h, after making the scratch compared to the control cells (Figure 4).

2.5. Stimulation of hTCEpi cells and Stromal Fibroblasts (SFs) by rhBMP7 Activates Vital Signaling Molecules

Since the corneal stromal cells also plays an equivalent role along with epithelial cells during wound healing response, we also included SFs along with epithelial cells in the present study to investigate the influence of BMP7-mediated signaling events. Stimulation of hTCEpi cells and SFs with BMP7 resulted to the activation of cellular signal transduction cascades after the addition of BMP7. Increased protein tyrosine phosphorylation, an indispensable mechanism of signal transduction, was observed after the addition of BMP7 to both hTCEpi cells and SFs (Figure 5).
Similarly, an increase in the phosphorylation of mitogen-activated protein kinase (MAPK) cascade proteins (p44/42 MAPK, pSAPK/JNK and p38) was also observed in both hTCEpi cells and SFs. Phosphorylation of p44/42 MAPK (ERK1/2) and p38 was increased immediately, within 5 min, after stimulation of hTCEpi cells with BMP7, whereas phosphorylation of SAPK/JNK shows a gradual increase after 5–15 min of BMP7 stimulations and reaches its peak activation at 30 min (Figure 6A). Furthermore, sustained phosphorylation of p44/42 MAPK and p38 was observed until 48 h in BMP7 stimulated epithelial cells. Similar results were obtained after stimulation of hTCEpi cells with TGF-β1 (Figure S2). Treatment of epithelial cells in the presence of MEK1/MEK2 inhibitor, U0126 (10 µM) completely abolished phosphorylation of p44/42 MAPK (Figure S3A) and further confirms the activation of Raf/MEK/ERK pathway during BMP7 stimulation. Additionally, stimulation of corneal epithelial cells in the presence of BMP7 antagonist noggin increases phosphorylation of p44/42 MAPK (Figure S3B).
Studies corresponding to the effect of BMP7 on primary SFs also showed an increased activation of p44/42 MAPK after 5 min along with p38. Activation of p44/42 MAPK and p38 was observed to sustain until 6 h. An increased phosphorylation of SAPK/JNK was observed at 30 min after BMP stimulation which was transient until 2 h after stimulation (Figure 6B).
As EMT-like phenomenon is also an important process during epithelial wound healing, we also considered to evaluate important activated EMT-related signaling molecules following BMP7 stimulation in hTCEpi cells. After BMP7 stimulation, differences in the phosphorylation levels of cofilin, a member of actin binding family, was observed which was decreased gradually by 48 h. Likewise, a decrease in the expression of claudin was also observed. Furthermore, we also observed an increase in the expression of transcription factor Zink finger E-box-binding homeobox 1 (ZEB1) immediately after stimulation with BMP7, which reaches its endogenous levels after 48 h of stimulation. A slight increase in the phosphorylation of ezrin/radixin/moesin (ERM) was also detected in epithelial cells upon stimulation with BMP7 (Figure 7).
Expression of α-smooth muscle actin (SMA) in stromal cells is an important phenomenon of transforming into repair phenotype during wound healing response. To study the role of BMP7 in transforming SFs into myofibroblasts, SFs were cultured in the presence of BMP7 and α-SMA expression was analyzed by immunocytochemistry. Figure 8A–C represent control SFs. We observed expression of α-SMA in SFs after 72 h treatment with BMP7 (Figure 8D,E) which indicates transformation of SFs into active myofibroblasts. Additionally, we also observed an increase in the vinculin stained focal adhesions, which regulate cell migration, upon stimulation with BMP7 (Figure 8F). TGF-β1 stimulated SFs served as a positive control (Figure 8G–I) in our experiments. Furthermore, in contrast to our observations in corneal epithelial cells, we observed decreased expression of phosphorylated ERM, Zeb1 expression and increased phosphorylation of cofilin in SFs following BMP7 stimulation after 24 h (Figure S4).

2.6. Elevated Phosphorylation of Epidermal Growth Factor Receptor (EGFR) Following rhBMP7 Stimulation

Stimulation of hTCEpi cells and SFs with BMP7 also resulted to the activation of EGFR along with MAPK signaling pathway. Elevated phosphorylation of EGFR at Tyr1045 and at Tyr992 was observed immediately after BMP7 stimulation (Figure 9). In epithelial cells, phosphorylation of EGFR at Tyr1045 and Tyr992 reached its maximum by 30 min and decreased gradually to its normal endogenous levels after 24 h of stimulation (Figure 9A). In SFs, we observed sustained activation of EGFR at Tyr992 until 48 h of stimulation whereas EGFR at Tyr1045 reached its endogenous levels by 48 h of stimulation with BMP7 (Figure 9B). No differences were observed in the total EGFR protein levels during the course of BMP7 stimulation. Similarly, compared to the BMP7 stimulation alone, no difference in the phosphorylation of EGFR observed when the epithelial cells were stimulated with BMP7 in the presence of its antagonist noggin (Figure S3B).

3. Discussion

In the human cornea, interactions between stromal and epithelial cells as well as epithelial and neuronal cells [44,45,46] play an important role in modulating the corneal function. In our previous study, we showed an increase in the expression of neuropeptide SP during corneal epithelial-trigeminal neuron interactions [40]. Similarly, NGF also produced constitutively in the human cornea by epithelial cells, SFs and modifies their functional activities [8,47]. Both SP and NGF are known to upregulate TGF-β1 mRNA and potentiate its production [6,7,48]. Since neuropeptides also regulate the corneal epithelial and stromal cell function [8,49,50,51], we also studied the effect of SP and NGF on the expression of BMP7 mRNA. Similar to the brain-derived neurotrophic factor induced expression of BMP7 [52], we also observed an enhanced BMP7 mRNA expression in corneal epithelial cells upon stimulation with SP and NGF whereas no such difference was observed in SFs. Thus, based on this observation along with the prominent role of BMP7 signaling in the modulation of cellular interactions [33], this study was designed to evaluate the effect of exogenous rhBMP7 on corneal epithelial and stromal cell function.
Transcriptome-wide gene-level expression profiling demonstrates relatively high number of differentially expressed genes as a result of rhBMP7 treatment on corneal epithelial cells. BMP7 treated corneal epithelial cells shows upregulation of TGF-β, cell cycle, JAK-STAT and MAPK signaling pathways. Further, gene ontology analysis predicts BMP7 involvement in the regulation of various vital biological processes such as regulation of cell cycle, cytoskeleton, intermediate filament and microtubule organization. BMP7 modulation of all these vital processes in corneal epithelial cells highlights its strong impact on epithelial cell function. In our study, of all differentially expressed BMP7 responsive genes, only TWSG1 was found to be downregulated. TWSG1 functions as an antagonist to BMPs [53] and its downregulation suggests a stimulatory function for BMP signaling [54]. In this context, its downregulation in corneal epithelial cells further confirms the activation of BMP signaling pathway. Among the various BMP target genes, we observed activation of ID1, ID2, ID3, FOXN1, SMAD6, SMAD7, DUSP1, BAMBI, BMP2, and MSX2 genes [55,56,57] after stimulation of corneal epithelial cells with BMP7. Subsequently, different DUSPs are also observed to be upregulated in our study similar to the treatment of BMP6 [55]. Epsin 3 is known to serve an important function in activated epithelial cells during tissue morphogenesis [58] and BMP7 stimulated expression of Epsin 3 in corneal epithelial cells may also help in modulating the activation of epithelial cells. Furthermore, LOX, a copper-containing amine oxidase which is known to be upregulated by BMP2/4 [59], is also upregulated upon BMP7 stimulation of corneal epithelial cells. Since LOX is also an inducer of EMT-like response [60,61], its upregulation denotes possible involvement of BMP7 in EMT-like phenomenon of corneal epithelial cells.
During BMP7 stimulation of corneal epithelial cells, we observed changes in some of the actin cytoskeleton regulating molecules and EMT-related proteins. Cofilin is an actin binding phosphoprotein and different cellular responses alter its phosphorylation levels [62,63]. Phosphorylation inactivates cofilin and cells require dephosphorylated cofilin to induce actin assembly and lamellipodium extension to ensue cell motility [64,65]. The observed gradual dephosphorylation of cofilin after BMP7 stimulation may activates cofilin and plays crucial role in the regulation of actin cytoskeleton remodeling, an important determinant of cell motility. By linking actin filaments to plasma membrane, ERM proteins involved in cell–cell adhesion, cytoskeleton organization as well as in signaling [66]. Furthermore, ERM protein phosphorylation is shown to be important for cell movement [67,68] and the observed small increase in the phosphorylation levels following BMP7 stimulation may contribute to the motility of cells. Additionally, tight junction (TJ) protein claudin also functions as a motility molecule [69] and its decreased expression enhances cell migration [70] in certain cell-types. Similarly, during the initiation of EMT, disrupted TJs lead to the reduced expression of claudin and other TJ proteins [71,72]. The observed decline in the claudin expression levels following BMP7 stimulation, along with decreased phosphorylation of cofilin, may also contribute to enhance cell migration and motility in corneal epithelial cells. Apart from the progression of EMT [72], Zeb1 is also participates in regulation of cell proliferation [73,74] and its expression is known to be induced by TGF-β and growth factor activated MAPK signaling pathways [75,76,77]. Similar to these reports, the observed increase in Zeb1 expression after BMP7 stimulation accompanied by increased MAPK pathway may correlate cell proliferation and EMT-like phenomenon in our study.
Adaptation of cells from a sedentary to the migratory phenotype is an important process of EMT [78]. Activation of MAPK cascade components (ERK1/2, JNK and p38) is essential for the movement of corneal epithelial cells [79,80,81] as well as EMT [82]. Additionally, BMP7 stimulation also leads to the activation of MAPK pathway [38,83,84] and is involved in both progression [38] as well as reversal of epithelial-to-mesenchymal transition (EMT)-like phenomenon [85]. Upon stimulation with BMP7, corneal epithelial cells show persistent activation of MAPK cascade proteins p44/42 MAPK and p38 up to 48 h, whereas JNK was activated only transiently. Since it is known that activated MAPK cascades facilitate expression of EMT-associated transcription factors [72], BMP7 induced MAPK proteins also may participate in the initiation of EMT-like responses. Taking together, our results along with literature reports support the notion that BMP7 may play an important role in the EMT-like phenomenon during corneal epithelial cell migration.
During corneal tissue repair, stimulation by growth factors activates p44/42 MAPK and p38 proteins, but not of JNK, and their cross talk is essential to synchronize the dynamics of wound healing process [86]. Accordingly, we also found activated p44/42 MAPK and p38 pathways following BMP7 stimulation in corneal epithelial cells and SFs. Activation of JNK was only transient following BMP7 stimulation and reaches its endogenous levels. Generally, in the corneal cells JNK is activated under stress-related circumstances [87,88] and inhibition of its activation potentially increases the damage repair response [88]. Furthermore, since JNK is also known as stress-activated protein kinase and its activation is dependent mainly on the type of stimulation [89], in our study, signaling events initiated by BMP7 stimulation may drive cell survival mechanisms by suppressing the activation of JNK and thereby enhance repair process. Similarly, stimulation of p44/42 MAPK and p38 is necessary for the α-SMA expression and transformation of fibroblasts into myofibroblasts [90,91,92,93,94]. In the present study, the observed activation of p44/42 MAPK and p38 following stimulation of SFs with BMP7 along with the expression of α-SMA may also suggest the involvement of activated MAPK cascade proteins in the differentiation of SFs into myofibroblasts.
Another important aspect of the present study is documentation of the cross talk between BMP7 and EGFR signaling. EGFR, with its intrinsic tyrosine kinase activity, triggers signaling pathways related to migration, proliferation and EMT [95]. EGFR serves as a predominant receptor for multiple ligands and is activated by endogenous growth factors such as EGF and TGF-α [96]. Activated EGFR plays an important role in the corneal epithelial cell and SFs proliferation and migration [97,98]. Correspondingly, in the present study, during stimulation with BMP7, EGFR was activated, phosphorylated at Tyr1045 and Tyr992 without any change in the total EGFR protein levels and its phosphorylation levels remain elevated for as long as 24 h. BMP7 regulation of EGFR was also reported in hepatic stellate cells [29] and astrocytes [99] which can modulate different cellular functions. Since EGFR-mediated signals reported to also activate MAPK cascades and thereby regulate diverse cellular functions [96,100], the ongoing cross talk between BMP7 and EGFR may have a potential role in corneal epithelial cell function and may enhance their migration. The documented augmentation of epithelial proliferation and migration after treatment with BMP7 could also reflect the synergistic consequence of activated EGFR. EGFR phosphorylation at Tyr992 acts as a high-affinity binding site for phospholipase Cγ and also activates MAPK cascade [101], whereas phosphorylation of EGFR at Tyr1045 serves as a binding site for c-Cbl which inhibits EGFR signaling by inducing receptor degradation [102]. Moreover, activation of EGFR by TGF family members results in receptor recycling [96] as well as MAPK activation [103]. Nevertheless, because of the contrasting implications of EGFR phosphorylation at Tyr1045 as well as Tyr992, and since BMP7 phosphorylates EGFR at both tyrosine residues, it is challenging to conclude the outcome of BMP7 stimulated EGFR activation in corneal epithelial cells and SFs. Furthermore, as the activated EGFR stimulates signaling events necessary for the generation of cell contractile force [104,105] through MAPK pathway [106,107] the observed activation of EGFR and MAPK signaling by BMP7 may enhance cell motility and migration during wound healing in both corneal epithelial cells and SFs.
Even though we did not observe any difference in the BMP7 expression by SP and NGF in SFs, they still respond to BMP7 stimulation in a manner similar to epithelial cells indicating a role for BMP7-mediated pathways in wound healing. Similar to the corneal epithelial cells, primary SFs also show an increase in the tyrosine phosphorylation following BMP7 stimulation. SFs display characteristics similar to smooth muscle cells and transform into myofibroblasts by expressing focal adhesions in the presence of TGF-β [108]. Similarly, the observed increase in the expression of α-SMA and focal adhesions upon BMP7 stimulation shows that BMP7 mimics the role of TGF-β in SFs which may also assist in increasing their contractile activity [109]. Furthermore, BMP7 induced expression of α-SMA is also reported in hepatic stellate cells [110]. This is in contrast to the in vivo observations where the presence of BMP7 suppressed expression levels of α-SMA [35,36]. In general, cellular response to growth regulating cytokines is influenced by the density of cells [111], which further affect the number of receptors present on their surface. A decrease in receptor number with an increase in cell density was observed for EGF [112], TNF [111] and TGF-β [113] receptors. Since BMP7 gene expression also resulted to the increased cell proliferation in vivo, occurrence of density-dependent reduction in BMP7 receptors may also happen due to the increased cell density, which may lead to the reduced BMP7 signaling and decreased expression of α-SMA in contrast to our observation of increased α-SMA expression in vitro. An increase in the levels of vinculin [108], a major component of the focal adhesions, following BMP7 treatment further shows the activated state of SFs and supports our assumption. Furthermore, since epithelial cell injury augments SFs myodifferentiation by increasing the secretion of TGF-β [114], the observed increase of BMP7 mRNA in corneal epithelial cells and BMP7 stimulated α-SMA expression in SFs may also play a vital role during corneal wound healing response.
Taken together, our results indicate a close correlation between the actions of TGF-β and BMP7 in corneal epithelial and stromal cell function. Both cytokines belongs to the same TGF-β superfamily and share similar downstream canonical Smad-dependent signaling pathways [115], display similar gene expression profiles [116], and are known to induce EMT. Our transcriptome analysis data also revealed the activation of TGF-β signaling pathway in corneal epithelial cells following the addition of BMP7. TGF-β mediated increased expression of α-SMA transform fibroblasts into activated myofibroblasts. Similarly, in this study, we also showed BMP7 mediated expression of α-SMA in SFs which may activate and transform them into myofibroblasts. TGF-β can induce activation of MAPK cascades, transactivation of EGFR [27,72], and we also demonstrated the activation of MAPK cascade upon BMP7 stimulation in corneal epithelial cells and SFs along with transactivation of EGFR. TGF-β1-mediated transactivation of EGFR occurs during corneal stromal cell differentiation [30] and we also showed the EGFR transactivation by BMP7 in SFs. Similar to the regulation of TGF-β, BMP7 expression was also regulated by SP and NGF. Furthermore, BMP7- mediated cellular responses that were observed in the present study are shown in Figure S5. In the corneal epithelial cells, BMP7 stimulated consequences including increased cell migration, increased Zeb1 levels, decreased claudin expression, activation of MAPK cascades and increased LOX expression were also reported to be EMT-like responses. Based on the results presented in this study, it is likely that BMP7 may also contribute to EMT-like responses and play a role equivalent to TGF-β during the course of corneal tissue repair. Furthermore, our transcriptome analysis data on corneal epithelial cells can be helpful to comprehend differentially expressed genes and activated pathways and may contribute to the development of novel therapeutic targets.

4. Materials and Methods

4.1. Materials

The following antibodies used in the present study were purchased from Cell Signaling Technology (Frankfurt, Germany): EGF receptor (Cat No. 4267), phospho-EGF receptor (Tyr1068) (Cat No. 3777), phospho-EGF receptor (Tyr992) (Cat No. 2235), phospho-tyrosine (Cat No. 9411), β-Actin (Cat No. 4970), phospho-SAPK/JNK (Cat No. 4668), phospho-p38 MAPK (Cat No. 4511), phospho-p44/42 MAPK (Cat No. 4370), claudin-1 (Cat No. 13255), phospho-cofilin (Cat No. 3313), TCF8/ZEB1 (Cat No. 3396) and phospho-ERM (Cat No. 3726). Alpha-SMA (Cat No. ab5694) was from Abcam, Cambridge, UK. Vinculin (Cat No. V9131) antibody was from Sigma-Aldrich (Munich, Germany). Anti-rabbit IgG- HRP antibody (Cat No. 7074) and anti-mouse IgG-HRP antibody (Cat No. 7076) were purchased from Cell Signaling Technology (Frankfurt, Germany). TPP tissue culture flasks, dishes and 6- and 12-well plates were obtained from Sigma-Aldrich (Munich, Germany). Coverslips and glass slides were from Marienfeld (Bonn, Germany). ECL prime detection western blotting reagent was purchased from Amersham and other western blotting reagents were from Bio-Rad (Munich, Germany). SP was purchased from Tocris (Wiesbaden-Nordenstadt, Germany). rh BMP7 (Cat No. 11343293) and rh TGF-β1 (Cat No. 11343161), rh NGF (Cat No. 11343354) were purchased from ImmunoTools (Friesoythe, Germany). rh noggin (Cat No. SRP4675) was purchased from Sigma-Aldrich (Munich, Germany). QuantiTect Reverse Transcription kit was purchased from Qiagen (Hilden, Germany), and the innuMIX qPCR MasterMix SyGreen was from Analytik-Jena (Jena, Germany). Primers were synthesized from Metabion GmbH (Martinsried, Germany). U0126 (Cat No. 9903) was purchased from Cell Signaling Technology (Frankfurt, Germany).

4.2. Cell Culture

This study was approved by the ethics committee of the University of Rostock and followed the guidelines of the Declaration of Helsinki.
Telomerase-immortalized human corneal epithelial cell line [117] (a kind gift of Prof. J. V. Jester, University of California, Irvine, CA, USA; authenticated and characterized according to ATCC standard protocols), between passages 22 and 30, was used in this present study. The hTCEpi cells were cultured in KGM-Gold™ growth medium (Lonza, Köln, Germany). Cells were sub-cultured on T75 tissue culture flasks (Sigma-Aldrich, Munich, Germany), incubated at 37 °C in 5% CO2 and passaged every 5–7 days.
Primary human SFs were cultured using an explant culture method, in DMEM with low glucose (Sigma-Aldrich, Munich, Germany) supplemented with 10% FCS, after collecting corneas from donor cadavers. SFs were seen growing out of the corneal explants after 3–4 days. When outgrowing primary SFs reached a confluent monolayer, cells were trypsinized and sub-cultured. For experimental analysis, SFs of third passage was used. The mesenchymal origin of the cells was confirmed by vimentin antibody immune staining.
In the present study, cells were treated with 100 ng/mL of rh BMP7 [118,119,120], which is less than the concentration of BMP7 used in other studies on corneal keratocytes and epithelial cells [34,121]. No toxic effects on epithelial cells and SFs were observed while using rhBMP7. TGF-β1 expression is known to be increased during injury in cultured SFs [122], which further helps SFs to differentiate into myofibroblasts [123]. Due to this reason, we also used TGF-β1 isoform at the concentration of 10 ng/mL in this present study. During stimulation of cells with BMP7 or TGF-β1, cells were growth factor- or serum-starved for 24 h before stimulation and cell culture media deprived of growth factors or serum was used. SP and NGF were used at the concentrations of 10−5 M and 100 ng/mL.

4.3. Microarray Hybridization

The cells were lysed in RTL Plus buffer, part of the RNeasy Plus Kit (Qiagen, Hilden, Germany) and extracted according to the manufacturers protocol. The whole RNA samples were quantified spectrophotometrically (NanoDrop, Thermo Fisher, Darmstadt, Germany) and the integrity was controlled using the Agilent Bioanalyzer 2100 with the RNA Nano chip kit (Agilent Genomics, Waldbronn, Germany). RNA integrity number values between 9.0 and 9.8 were achieved and 200 ng were used as starting material. To perform the Expression Profiling, Affymetrix ClariomTM S Arrays were used according to the manufacturer’s instructions (Affymetrix, St. Clara, CA, USA). The hybridization was carried out overnight at 45 °C in the GeneChip® Hybridisation Oven 645 (Affymetrix). The microarray was scanned using the GeneChip Scanner 3000 (Affymetrix) at 0.7 micron resolution.

4.4. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)

Total RNA was isolated from cultured corneal epithelial cells or SFs using the NucleoSpin® RNA kit (Macherey-Nagel, Berlin, Germany) according to the manufacturer’s instructions. Single-stranded cDNA was prepared with 1 µg of total RNA using QuantiTect Reverse Transcription kit (Qiagen, Hilden, Germany). Intron/exon spanning primers were designed from the respective GenBank sequences using VectorNTI software (Invitrogen) based on minimal hairpin, duplex formation and guanine cytosine composition. List of primers used in this study is given in Table 4.
The synthesized cDNA then was used as a template for qRT-PCR using the innuMIX qPCR MasterMix SyGreen and qTower 2.0 (Analytik Jena, Jena, Germany). The cycling conditions used for amplification were 95 °C for 2 min, 40 cycles of 95 °C for 5 s and 65 °C for 25 s. Later, the expression of all genes was normalized to the expression of the corresponding housekeeping gene, GAPDH. The relative amount of target mRNA in the unstimulated control cells and BMP7 treated cells was analyzed using the ΔΔCt method, as described previously [124].

4.5. Immunofluorescence

Human primary SFs grown on glass coverslips were fixed with 4% paraformaldehyde for 10 min after washing with PBS and then permeabilized with PBS containing 0.1% Triton X-100 (Sigma-Aldrich, Munich, Germany) for 30 min. Fixed and permeabilized cells were then incubated with primary antibodies for intracellular staining. All primary antibodies in this study were used at 1:100 dilutions in PBS containing 0.1% Triton X-100 with 2% FCS and incubated for 60 min at room temperature. The cells were then washed with PBS before adding secondary donkey anti-mouse IgG (H+L)-Alexa Fluor 488 (diluted 1:50) or donkey anti-rabbit IgG (H+L)-Cy3 (diluted 1:100) and incubated at room temperature for another 60 min. Later, cells were washed 3 times with PBS and mounted in mounting medium (Vector Labs, Eching, Germany) containing 4,6-diamidino-2-phenylindole (DAPI). During immunostaining, cells stained with only secondary antibodies and did not show any specific staining served as a control. Cells were observed under a Nikon confocal fluorescence microscope equipped with digital camera (Nikon Eclipse E400 with D-Eclipse C1) and all images were taken from a single plane through the cell monolayers with 40× objective using the same settings.

4.6. Immunoblotting

Corneal epithelial or SFs monolayers were washed with PBS and lysed in RIPA buffer (Sigma-Aldrich, Munich, Germany) containing protease and phosphatase inhibitors (Roche, Mannheim, Germany). Equal amounts of total cell lysates (30 µg protein per lane) were loaded into the wells and separated by SDS-PAGE using 10% Mini-PROTEAN® TGX™ precast gels (Bio-Rad, Munich, Germany) and transferred onto PVDF membranes (Bio-Rad, Munich, Germany). Later, membranes were blocked with 5% non-fat dry milk (Carl Roth, Karlsruhe, Germany) in Tris-buffered saline with Tween-20 (Sigma-Aldrich, Munich, Germany) (TBS-T) for 30 min and incubated with respective primary antibodies (diluted 1:1000) overnight at 4 °C. After washing 3 times with TBS-T, membranes were incubated with secondary HRP-conjugated anti-rabbit or anti-mouse IgG (diluted 1:2500) for an additional 1 h at room temperature and developed to visualize protein bands using the enhanced chemiluminescence detection system (Amersham). During quantification, optical density of each protein band was normalized to the corresponding β-actin or GAPDH band. Quantification of the blots was performed using ImageJ software [125].

4.7. Scratch Assay

Migration of corneal epithelial cells was assessed by performing an in vitro scratch assay in which a linear scratch midline was made across the bottom of the dish on a confluent monolayer of epithelial cells using a 200 µL sterile pipet tip. After that, cells were rinsed gently with PBS to remove any remaining cell debris. KGM-Gold™ medium deprived of growth factors was used during the scratch assay. BMP7 was used at a concentration as mentioned earlier with fresh medium. Later, pictures were taken at 10× magnifications using a microscope equipped with Moticam10 digital camera at time points 10 and 24 h. Epithelial cell migration across the scratch line was then quantified by counting the cells invading the central scratch area in either the control or the BMP7 treated culture dish. The cell number was later represented for both conditions in each sample.

4.8. Statistical Analyses

Bar charts and line plots were generated using means and the standard deviation. Student’s t-test was used for the comparison between two groups and p-values of <0.05 were considered statistically significant and are indicated by asterisks.

Supplementary Materials

The supplementary materials are available online at https://www.mdpi.com/1422-0067/19/5/1415/s1.

Author Contributions

B.S.K. designed the study, performed the cell cultures and experiments, biochemical studies, analyzed the data and drafted the manuscript; D.K. performed microarray studies; R.K.P. and R.M. performed statistical analysis; and A.W., T.S., A.G.M.J. and O.S. helped in drafting the manuscript and participated in the coordination of the study. All authors read and approved the final manuscript.

Funding

This work was financially supported by Deutsche Forschungsgemeinschaft (DFG) (KO-4979/1-1).

Acknowledgments

The authors thank Deutsche Ophthalmologische Gesellschaft (DOG) for their initial funding. We also thank James V Jester for providing immortalized hTCEpi cells and the group of Rainer Bader, Department of Orthopaedics, University of Rostock for assisting our qRT-PCR experiments.

Conflicts of Interest

The authors declare no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Abbreviations

α-SMAAlpha smooth muscle actin
ATP1β1ATPase, Na+/K+ transporting, beta 1
BMP7Bone morphogenetic protein 7
CRYABCrystallin alpha B
DSG4Desmoglein 4
DUSP14Dual specificity phosphatase 14
EGFEpidermal growth factor
EGFREpidermal growth factor receptor
ERMEzrin/radixin/moesin
EPN3Epsin 3
EMTEpithelial-to-mesenchymal transition
ERKExtracellular signal-regulated kinase
GEPGene expression profiling
hTCEpiTelomerase-immortalized human corneal epithelial cell line
IDInhibitor of DNA-binding
LOXLysyl oxidase
MAPKMitogen-activated protein kinase
NGFNerve growth factor
SFsCorneal stromal fibroblasts
SPSubstance P
TGF-βTransforming growth factor beta
TGM5transglutaminase 5
TNFTumor necrosis factor
ZEB1Zinc finger E-box-binding homeobox1

References

  1. Schultz, G.; Chegini, N.; Grant, M.; Khaw, P.; MacKay, S. Effects of growth factors on corneal wound healing. Acta Ophthalmol. Suppl. 1992, 60–66. [Google Scholar] [CrossRef]
  2. West-Mays, J.A.; Dwivedi, D.J. The keratocyte: Corneal stromal cell with variable repair phenotypes. Int. J. Biochem. Cell Biol. 2006, 38, 1625–1631. [Google Scholar] [CrossRef] [PubMed]
  3. Kowtharapu, B.S.; Murin, R.; Junemann, A.G.M.; Stachs, O. Role of corneal stromal cells on epithelial cell function during wound healing. Int. J. Mol. Sci. 2018, 19. [Google Scholar] [CrossRef] [PubMed]
  4. Imanishi, J.; Kamiyama, K.; Iguchi, I.; Kita, M.; Sotozono, C.; Kinoshita, S. Growth factors: Importance in wound healing and maintenance of transparency of the cornea. Prog. Retin. Eye Res. 2000, 19, 113–129. [Google Scholar] [CrossRef]
  5. Yu, F.S.; Yin, J.; Xu, K.; Huang, J. Growth factors and corneal epithelial wound healing. Brain Res. Bull. 2010, 81, 229–235. [Google Scholar] [CrossRef] [PubMed]
  6. Yaraee, R.; Ghazanfari, T. Substance P potentiates TGF-β1 production in lung epithelial cell lines. Iran. J. Allergy Asthma Immunol. 2009, 8, 19–24. [Google Scholar] [PubMed]
  7. Hu, D.; Chen, B.; Zhu, X.; Tao, K.; Tang, C.; Wang, J. Substance P up-regulates the TGF-β1 mRNA expression of human dermal fibroblasts in vitro. Zhonghua Zheng Xing Wai Ke Za Zhi. 2002, 18, 234–236. [Google Scholar] [PubMed]
  8. Micera, A.; Lambiase, A.; Puxeddu, I.; Aloe, L.; Stampachiacchiere, B.; Levi-Schaffer, F.; Bonini, S.; Bonini, S. Nerve growth factor effect on human primary fibroblastic-keratocytes: Possible mechanism during corneal healing. Exp. Eye Res. 2006, 83, 747–757. [Google Scholar] [CrossRef] [PubMed]
  9. Saika, S. TGF-β signal transduction in corneal wound healing as a therapeutic target. Cornea 2004, 23, S25–S30. [Google Scholar] [CrossRef] [PubMed]
  10. Tandon, A.; Tovey, J.C.; Sharma, A.; Gupta, R.; Mohan, R.R. Role of transforming growth factor beta in corneal function, biology and pathology. Curr. Mol. Med. 2010, 10, 565–578. [Google Scholar] [PubMed]
  11. Bragdon, B.; Moseychuk, O.; Saldanha, S.; King, D.; Julian, J.; Nohe, A. Bone morphogenetic proteins: A critical review. Cell Signal 2011, 23, 609–620. [Google Scholar] [CrossRef] [PubMed]
  12. Wordinger, R.J.; Clark, A.F. Bone morphogenetic proteins and their receptors in the eye. Exp. Biol. Med. 2007, 232, 979–992. [Google Scholar] [CrossRef] [PubMed]
  13. Sanchez-Duffhues, G.; Hiepen, C.; Knaus, P.; Ten Dijke, P. Bone morphogenetic protein signaling in bone homeostasis. Bone 2015, 80, 43–59. [Google Scholar] [CrossRef] [PubMed]
  14. Wang, R.N.; Green, J.; Wang, Z.; Deng, Y.; Qiao, M.; Peabody, M.; Zhang, Q.; Ye, J.; Yan, Z.; Denduluri, S.; et al. Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes Dis. 2014, 1, 87–105. [Google Scholar] [CrossRef] [PubMed]
  15. Walsh, D.W.; Godson, C.; Brazil, D.P.; Martin, F. Extracellular BMP-antagonist regulation in development and disease: Tied up in knots. Trends Cell Biol. 2010, 20, 244–256. [Google Scholar] [CrossRef] [PubMed]
  16. Brazil, D.P.; Church, R.H.; Surae, S.; Godson, C.; Martin, F. BMP signalling: Agony and antagony in the family. Trends Cell Biol. 2015, 25, 249–264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Salazar, V.S.; Gamer, L.W.; Rosen, V. BMP signalling in skeletal development, disease and repair. Nat. Rev. Endocrinol. 2016, 12, 203–221. [Google Scholar] [CrossRef] [PubMed]
  18. Huang, J.; Liu, Y.; Filas, B.; Gunhaga, L.; Beebe, D.C. Negative and positive auto-regulation of BMP expression in early eye development. Dev. Biol. 2015, 407, 256–264. [Google Scholar] [CrossRef] [PubMed]
  19. Kuribayashi, H.; Baba, Y.; Watanabe, S. BMP signaling participates in late phase differentiation of the retina, partly via upregulation of hey2. Dev. Neurobiol. 2014, 74, 1172–1183. [Google Scholar] [CrossRef] [PubMed]
  20. Faber, S.C.; Robinson, M.L.; Makarenkova, H.P.; Lang, R.A. BMP signaling is required for development of primary lens fiber cells. Development. 2002, 129, 3727–3737. [Google Scholar] [PubMed]
  21. Zhao, S.; Chen, Q.; Hung, F.C.; Overbeek, P.A. Bmp signaling is required for development of the ciliary body. Development. 2002, 129, 4435–4442. [Google Scholar] [PubMed]
  22. You, L.; Kruse, F.E.; Pohl, J.; Volcker, H.E. Bone morphogenetic proteins and growth and differentiation factors in the human cornea. Invest Ophthalmol Vis Sci. 1999, 40, 296–311. [Google Scholar] [PubMed]
  23. Mohan, R.R.; Kim, W.J.; Mohan, R.R.; Chen, L.; Wilson, S.E. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Investig. Ophthalmol. Vis. Sci. 1998, 39, 2626–2636. [Google Scholar]
  24. Ljubimov, A.V.; Saghizadeh, M. Progress in corneal wound healing. Prog. Retin. Eye Res. 2015, 49, 17–45. [Google Scholar] [CrossRef] [PubMed]
  25. Wang, Z. Transactivation of epidermal growth factor receptor by g protein-coupled receptors: Recent progress, challenges and future research. Int. J. Mol. Sci. 2016, 17. [Google Scholar] [CrossRef] [PubMed]
  26. Fischer, O.M.; Hart, S.; Gschwind, A.; Ullrich, A. EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 2003, 31, 1203–1208. [Google Scholar] [CrossRef] [PubMed]
  27. Forrester, S.J.; Kawai, T.; O’Brien, S.; Thomas, W.; Harris, R.C.; Eguchi, S. Epidermal growth factor receptor transactivation: Mechanisms, pathophysiology, and potential therapies in the cardiovascular system. Annu. Rev. Pharmacol. Toxicol. 2016, 56, 627–653. [Google Scholar] [CrossRef] [PubMed]
  28. McCarty, M.F. A role for cAMP-driven transactivation of egfr in cancer aggressiveness—Therapeutic implications. Med. Hypotheses 2014, 83, 142–147. [Google Scholar] [CrossRef] [PubMed]
  29. Wang, L.P.; Dong, J.Z.; Xiong, L.J.; Shi, K.Q.; Zou, Z.L.; Zhang, S.N.; Cao, S.T.; Lin, Z.; Chen, Y.P. BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor. Int. J. Clin. Exp. Pathol. 2014, 7, 3537–3547. [Google Scholar] [PubMed]
  30. He, J.; Bazan, H.E. Epidermal growth factor synergism with TGF-β1 via PI-3 kinase activity in corneal keratocyte differentiation. Investig. Ophthalmol. Vis. Sci. 2008, 49, 2936–2945. [Google Scholar] [CrossRef] [PubMed]
  31. Lyu, J.; Lee, K.S.; Joo, C.K. Transactivation of EGFR mediates insulin-stimulated erk1/2 activation and enhanced cell migration in human corneal epithelial cells. Mol. Vis. 2006, 12, 1403–1410. [Google Scholar] [PubMed]
  32. Spix, J.K.; Chay, E.Y.; Block, E.R.; Klarlund, J.K. Hepatocyte growth factor induces epithelial cell motility through transactivation of the epidermal growth factor receptor. Exp. Cell Res. 2007, 313, 3319–3325. [Google Scholar] [CrossRef] [PubMed]
  33. Dudley, A.T.; Lyons, K.M.; Robertson, E.J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 1995, 9, 2795–2807. [Google Scholar] [CrossRef] [PubMed]
  34. Chung, J.K.; Park, S.A.; Hwang, H.S.; Kim, K.S.; Cho, Y.J.; You, Y.S.; Kim, Y.S.; Jang, J.W.; Lee, S.J. Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis. Int. J. Ophthalmol. 2017, 10, 329–335. [Google Scholar] [CrossRef] [PubMed]
  35. Saika, S.; Ikeda, K.; Yamanaka, O.; Flanders, K.C.; Nakajima, Y.; Miyamoto, T.; Ohnishi, Y.; Kao, W.W.; Muragaki, Y.; Ooshima, A. Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice. Lab. Investig. 2005, 85, 474–486. [Google Scholar] [CrossRef] [PubMed]
  36. Tandon, A.; Sharma, A.; Rodier, J.T.; Klibanov, A.M.; Rieger, F.G.; Mohan, R.R. BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo. PLoS ONE 2013, 8, e66434. [Google Scholar] [CrossRef] [PubMed]
  37. Aomatsu, K.; Arao, T.; Sugioka, K.; Matsumoto, K.; Tamura, D.; Kudo, K.; Kaneda, H.; Tanaka, K.; Fujita, Y.; Shimomura, Y.; et al. TGF-β induces sustained upregulation of SNAI1 and SNAI2 through smad and non-smad pathways in a human corneal epithelial cell line. Investig. Ophthalmol. Vis. Sci. 2011, 52, 2437–2443. [Google Scholar] [CrossRef] [PubMed]
  38. Lim, M.; Chuong, C.M.; Roy-Burman, P. PI3K, ERK signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures. Horm. Cancer 2011, 2, 298–309. [Google Scholar] [CrossRef] [PubMed]
  39. Gupta, S.; Fink, M.K.; Ghosh, A.; Tripathi, R.; Sinha, P.R.; Sharma, A.; Hesemann, N.P.; Chaurasia, S.S.; Giuliano, E.A.; Mohan, R.R. Novel combination BMP7 and HGF gene therapy instigates selective myofibroblast apoptosis and reduces corneal haze in vivo. Investig. Ophthalmol. Vis. Sci. 2018, 59, 1045–1057. [Google Scholar] [CrossRef] [PubMed]
  40. Kowtharapu, B.S.; Stahnke, T.; Wree, A.; Guthoff, R.F.; Stachs, O. Corneal epithelial and neuronal interactions: Role in wound healing. Exp. Eye Res. 2014, 125, 53–61. [Google Scholar] [CrossRef] [PubMed]
  41. Segklia, A.; Seuntjens, E.; Elkouris, M.; Tsalavos, S.; Stappers, E.; Mitsiadis, T.A.; Huylebroeck, D.; Remboutsika, E.; Graf, D. BMP7 regulates the survival, proliferation, and neurogenic properties of neural progenitor cells during corticogenesis in the mouse. PLoS ONE 2012, 7, e34088. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Wang, S.N.; Lapage, J.; Hirschberg, R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. 2001, 12, 2392–2399. [Google Scholar] [PubMed]
  43. Hata, A.; Lagna, G.; Massague, J.; Hemmati-Brivanlou, A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the smad4 tumor suppressor. Genes Dev. 1998, 12, 186–197. [Google Scholar] [CrossRef] [PubMed]
  44. Wilson, S.E.; Liu, J.J.; Mohan, R.R. Stromal-epithelial interactions in the cornea. Prog. Retin. Eye Res. 1999, 18, 293–309. [Google Scholar] [CrossRef]
  45. Wilson, S.E.; Netto, M.; Ambrosio, R., Jr. Corneal cells: Chatty in development, homeostasis, wound healing, and disease. Am. J. Ophthalmol. 2003, 136, 530–536. [Google Scholar] [CrossRef]
  46. Oswald, D.J.; Lee, A.; Trinidad, M.; Chi, C.; Ren, R.; Rich, C.B.; Trinkaus-Randall, V. Communication between corneal epithelial cells and trigeminal neurons is facilitated by purinergic (p2) and glutamatergic receptors. PLoS ONE 2012, 7, e44574. [Google Scholar] [CrossRef] [PubMed]
  47. Lambiase, A.; Manni, L.; Bonini, S.; Rama, P.; Micera, A.; Aloe, L. Nerve growth factor promotes corneal healing: Structural, biochemical, and molecular analyses of rat and human corneas. Investig. Ophthalmol. Vis. Sci. 2000, 41, 1063–1069. [Google Scholar]
  48. Kim, S.J.; Park, K.; Rudkin, B.B.; Dey, B.R.; Sporn, M.B.; Roberts, A.B. Nerve growth factor induces transcription of transforming growth factor-beta 1 through a specific promoter element in PC12 cells. J. Biol. Chem. 1994, 269, 3739–3744. [Google Scholar] [PubMed]
  49. Araki-Sasaki, K.; Aizawa, S.; Hiramoto, M.; Nakamura, M.; Iwase, O.; Nakata, K.; Sasaki, Y.; Mano, T.; Handa, H.; Tano, Y. Substance P-induced cadherin expression and its signal transduction in a cloned human corneal epithelial cell line. J. Cell Physiol. 2000, 182, 189–195. [Google Scholar] [CrossRef]
  50. Yang, L.; Sui, W.; Li, Y.; Qi, X.; Wang, Y.; Zhou, Q.; Gao, H. Substance P inhibits hyperosmotic stress-induced apoptosis in corneal epithelial cells through the mechanism of Akt activation and reactive oxygen species scavenging via the neurokinin-1 receptor. PLoS ONE 2016, 11, e0149865. [Google Scholar] [CrossRef] [PubMed]
  51. Blanco-Mezquita, T.; Martinez-Garcia, C.; Proenca, R.; Zieske, J.D.; Bonini, S.; Lambiase, A.; Merayo-Lloves, J. Nerve growth factor promotes corneal epithelial migration by enhancing expression of matrix metalloprotease-9. Investig. Ophthalmol. Vis. Sci. 2013, 54, 3880–3890. [Google Scholar] [CrossRef] [PubMed]
  52. Ortega, J.A.; Alcantara, S. BDNF/MAPK/ERK-induced BMP7 expression in the developing cerebral cortex induces premature radial glia differentiation and impairs neuronal migration. Cereb Cortex 2010, 20, 2132–2144. [Google Scholar] [CrossRef] [PubMed]
  53. Chang, C.; Holtzman, D.A.; Chau, S.; Chickering, T.; Woolf, E.A.; Holmgren, L.M.; Bodorova, J.; Gearing, D.P.; Holmes, W.E.; Brivanlou, A.H. Twisted gastrulation can function as a BMP antagonist. Nature 2001, 410, 483–487. [Google Scholar] [CrossRef] [PubMed]
  54. Sotillo Rodriguez, J.E.; Mansky, K.C.; Jensen, E.D.; Carlson, A.E.; Schwarz, T.; Pham, L.; MacKenzie, B.; Prasad, H.; Rohrer, M.D.; Petryk, A.; Gopalakrishnan, R. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling. J. Bone Miner. Res. 2009, 24, 1917–1926. [Google Scholar] [CrossRef] [PubMed]
  55. Phillips, M.A.; Qin, Q.; Hu, Q.; Zhao, B.; Rice, R.H. Arsenite suppression of BMP signaling in human keratinocytes. Toxicol. Appl. Pharmacol. 2013, 269, 290–296. [Google Scholar] [CrossRef] [PubMed]
  56. Miyazono, K.; Maeda, S.; Imamura, T. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005, 16, 251–263. [Google Scholar] [CrossRef] [PubMed]
  57. Miyazono, K.; Kamiya, Y.; Morikawa, M. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 2010, 147, 35–51. [Google Scholar] [CrossRef] [PubMed]
  58. Spradling, K.D.; McDaniel, A.E.; Lohi, J.; Pilcher, B.K. Epsin 3 is a novel extracellular matrix-induced transcript specific to wounded epithelia. J. Biol. Chem. 2001, 276, 29257–29267. [Google Scholar] [CrossRef] [PubMed]
  59. Huang, H.Y.; Chen, S.Z.; Zhang, W.T.; Wang, S.S.; Liu, Y.; Li, X.; Sun, X.; Li, Y.M.; Wen, B.; Lei, Q.Y.; et al. Induction of EMT-like response by BMP4 via up-regulation of lysyl oxidase is required for adipocyte lineage commitment. Stem Cell Res. 2013, 10, 278–287. [Google Scholar] [CrossRef] [PubMed]
  60. Kasashima, H.; Yashiro, M.; Kinoshita, H.; Fukuoka, T.; Morisaki, T.; Masuda, G.; Sakurai, K.; Kubo, N.; Ohira, M.; Hirakawa, K. Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia. Gastric Cancer 2016, 19, 431–442. [Google Scholar] [CrossRef] [PubMed]
  61. Wang, J.; Zhu, Y.; Tan, J.; Meng, X.; Xie, H.; Wang, R. Lysyl oxidase promotes epithelial-to-mesenchymal transition during paraquat-induced pulmonary fibrosis. Mol. Biosyst. 2016, 12, 499–507. [Google Scholar] [CrossRef] [PubMed]
  62. Chan, A.Y.; Bailly, M.; Zebda, N.; Segall, J.E.; Condeelis, J.S. Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion. J. Cell Biol. 2000, 148, 531–542. [Google Scholar] [CrossRef] [PubMed]
  63. Kiuchi, T.; Nagai, T.; Ohashi, K.; Mizuno, K. Measurements of spatiotemporal changes in G-actin concentration reveal its effect on stimulus-induced actin assembly and lamellipodium extension. J. Cell Biol. 2011, 193, 365–380. [Google Scholar] [CrossRef] [PubMed]
  64. Moriyama, K.; Iida, K.; Yahara, I. Phosphorylation of ser-3 of cofilin regulates its essential function on actin. Genes Cells 1996, 1, 73–86. [Google Scholar] [CrossRef] [PubMed]
  65. Kiuchi, T.; Ohashi, K.; Kurita, S.; Mizuno, K. Cofilin promotes stimulus-induced lamellipodium formation by generating an abundant supply of actin monomers. J. Cell Biol. 2007, 177, 465–476. [Google Scholar] [CrossRef] [PubMed]
  66. Louvet-Vallee, S. ERM proteins: From cellular architecture to cell signaling. Biol. Cell 2000, 92, 305–316. [Google Scholar] [CrossRef]
  67. Bosanquet, D.C.; Ye, L.; Harding, K.G.; Jiang, W.G. FERM family proteins and their importance in cellular movements and wound healing (review). Int. J. Mol. Med. 2014, 34, 3–12. [Google Scholar] [CrossRef] [PubMed]
  68. Ng, T.; Parsons, M.; Hughes, W.E.; Monypenny, J.; Zicha, D.; Gautreau, A.; Arpin, M.; Gschmeissner, S.; Verveer, P.J.; Bastiaens, P.I.; et al. Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J. 2001, 20, 2723–2741. [Google Scholar] [CrossRef] [PubMed]
  69. Webb, P.G.; Spillman, M.A.; Baumgartner, H.K. Claudins play a role in normal and tumor cell motility. BMC Cell Biol. 2013, 14. [Google Scholar] [CrossRef] [PubMed]
  70. Ikari, A.; Takiguchi, A.; Atomi, K.; Sato, T.; Sugatani, J. Decrease in claudin-2 expression enhances cell migration in renal epithelial Madin-Darby canine kidney cells. J. Cell. Physiol. 2011, 226, 1471–1478. [Google Scholar] [CrossRef] [PubMed]
  71. Huang, R.Y.; Guilford, P.; Thiery, J.P. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J. Cell. Sci. 2012, 125, 4417–4422. [Google Scholar] [CrossRef] [PubMed]
  72. Lamouille, S.; Xu, J.; Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014, 15, 178–196. [Google Scholar] [CrossRef] [PubMed]
  73. Liu, Y.; El-Naggar, S.; Darling, D.S.; Higashi, Y.; Dean, D.C. Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 2008, 135, 579–588. [Google Scholar] [CrossRef] [PubMed]
  74. Gu, Y.; Zhao, Y.; Zhou, Y.; Xie, Y.; Ju, P.; Long, Y.; Liu, J.; Ni, D.; Cao, F.; Lyu, Z.; et al. Zeb1 is a potential regulator of Six2 in the proliferation, apoptosis and migration of metanephric mesenchyme cells. Int J. Mol. Sci. 2016, 17. [Google Scholar] [CrossRef] [PubMed]
  75. Xu, J.; Lamouille, S.; Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19, 156–172. [Google Scholar] [CrossRef] [PubMed]
  76. Peinado, H.; Olmeda, D.; Cano, A. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat. Rev. Cancer 2007, 7, 415–428. [Google Scholar] [CrossRef] [PubMed]
  77. Graham, T.R.; Zhau, H.E.; Odero-Marah, V.A.; Osunkoya, A.O.; Kimbro, K.S.; Tighiouart, M.; Liu, T.; Simons, J.W.; O’Regan, R.M. Insulin-like growth factor-i-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 2008, 68, 2479–2488. [Google Scholar] [CrossRef] [PubMed]
  78. Barriere, G.; Fici, P.; Gallerani, G.; Fabbri, F.; Rigaud, M. Epithelial mesenchymal transition: A double-edged sword. Clin. Transl. Med. 2015, 4. [Google Scholar] [CrossRef] [PubMed]
  79. Terai, K.; Call, M.K.; Liu, H.; Saika, S.; Liu, C.Y.; Hayashi, Y.; Chikama, T.; Zhang, J.; Terai, N.; Kao, C.W.; et al. Crosstalk between TGF-β and MAPK signaling during corneal wound healing. Investig. Ophthalmol. Vis. Sci. 2011, 52, 8208–8215. [Google Scholar] [CrossRef] [PubMed]
  80. Okada, Y.; Saika, S.; Shirai, K.; Yamanaka, O.; Kitano, A.; Wang, Z.; Yang, H.; Reinach, P. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration. Ophthalmic Res. 2009, 42, 185–192. [Google Scholar] [CrossRef] [PubMed]
  81. Zelenka, P.S.; Arpitha, P. Coordinating cell proliferation and migration in the lens and cornea. Semin Cell. Dev. Biol. 2008, 19, 113–124. [Google Scholar] [CrossRef] [PubMed]
  82. Xie, L.; Law, B.K.; Chytil, A.M.; Brown, K.A.; Aakre, M.E.; Moses, H.L. Activation of the ERK pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 2004, 6, 603–610. [Google Scholar] [CrossRef] [PubMed]
  83. Blank, U.; Brown, A.; Adams, D.C.; Karolak, M.J.; Oxburgh, L. BMP7 promotes proliferation of nephron progenitor cells via a JNK-dependent mechanism. Development 2009, 136, 3557–3566. [Google Scholar] [CrossRef] [PubMed]
  84. Carreira, A.C.; Alves, G.G.; Zambuzzi, W.F.; Sogayar, M.C.; Granjeiro, J.M. Bone morphogenetic proteins: Structure, biological function and therapeutic applications. Arch. Biochem. Biophys. 2014, 561, 64–73. [Google Scholar] [CrossRef] [PubMed]
  85. Zeisberg, M.; Hanai, J.; Sugimoto, H.; Mammoto, T.; Charytan, D.; Strutz, F.; Kalluri, R. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 2003, 9, 964–968. [Google Scholar] [CrossRef] [PubMed]
  86. Sharma, G.D.; He, J.; Bazan, H.E. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: Evidence of cross-talk activation between MAP kinase cascades. J. Biol. Chem. 2003, 278, 21989–21997. [Google Scholar] [CrossRef] [PubMed]
  87. Wang, L.; Lu, L. Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 2007, 48, 652–660. [Google Scholar] [CrossRef] [PubMed]
  88. Kubilus, J.K.; Beazley, K.E.; Talbot, C.J.; Linsenmayer, T.F. Nuclear ferritin mediated regulation of JNK signaling in corneal epithelial cells. Exp. Eye Res. 2016, 145, 337–340. [Google Scholar] [CrossRef] [PubMed]
  89. Lin, A. Activation of the JNK signaling pathway: Breaking the brake on apoptosis. Bioessays 2003, 25, 17–24. [Google Scholar] [CrossRef] [PubMed]
  90. Hu, Y.; Peng, J.; Feng, D.; Chu, L.; Li, X.; Jin, Z.; Lin, Z.; Zeng, Q. Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced α smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung 2006, 184, 33–42. [Google Scholar] [CrossRef] [PubMed]
  91. Liu, X.; Sun, S.Q.; Hassid, A.; Ostrom, R.S. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and smad signaling in cardiac fibroblasts. Mol. Pharmacol. 2006, 70, 1992–2003. [Google Scholar] [CrossRef] [PubMed]
  92. Xing, D.; Bonanno, J.A. Effect of cAMP on TGF-β1-induced corneal keratocyte-myofibroblast transformation. Investig. Ophthalmol. Vis. Sci. 2009, 50, 626–633. [Google Scholar] [CrossRef] [PubMed]
  93. Sebe, A.; Leivonen, S.K.; Fintha, A.; Masszi, A.; Rosivall, L.; Kahari, V.M.; Mucsi, I. Transforming growth factor-beta-induced α-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38beta mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the smad signalling during epithelial-myofibroblast transdifferentiation. Nephrol. Dial. Transplant. 2008, 23, 1537–1545. [Google Scholar] [CrossRef] [PubMed]
  94. Stambe, C.; Atkins, R.C.; Tesch, G.H.; Masaki, T.; Schreiner, G.F.; Nikolic-Paterson, D.J. The role of p38α mitogen-activated protein kinase activation in renal fibrosis. J. Am. Soc. Nephrol. 2004, 15, 370–379. [Google Scholar] [CrossRef] [PubMed]
  95. Bodnar, R.J. Epidermal growth factor and epidermal growth factor receptor: The yin and yang in the treatment of cutaneous wounds and cancer. Adv. Wound Care 2013, 2, 24–29. [Google Scholar] [CrossRef] [PubMed]
  96. Wells, A. EGF receptor. Int. J. Biochem. Cell. Biol. 1999, 31, 637–643. [Google Scholar] [CrossRef]
  97. Zieske, J.D.; Takahashi, H.; Hutcheon, A.E.; Dalbone, A.C. Activation of epidermal growth factor receptor during corneal epithelial migration. Investig. Ophthalmol. Vis. Sci. 2000, 41, 1346–1355. [Google Scholar]
  98. Nakamura, Y.; Sotozono, C.; Kinoshita, S. The epidermal growth factor receptor (EGFR): Role in corneal wound healing and homeostasis. Exp. Eye Res. 2001, 72, 511–517. [Google Scholar] [CrossRef] [PubMed]
  99. Scholze, A.R.; Foo, L.C.; Mulinyawe, S.; Barres, B.A. BMP signaling in astrocytes downregulates EGFR to modulate survival and maturation. PLoS ONE 2014, 9, e110668. [Google Scholar] [CrossRef] [PubMed]
  100. Katz, M.; Amit, I.; Yarden, Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim. Biophys. Acta 2007, 1773, 1161–1176. [Google Scholar] [CrossRef] [PubMed]
  101. Sturla, L.M.; Amorino, G.; Alexander, M.S.; Mikkelsen, R.B.; Valerie, K.; Schmidt-Ullrichr, R.K. Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. J. Biol Chem. 2005, 280, 14597–14604. [Google Scholar] [CrossRef] [PubMed]
  102. Levkowitz, G.; Waterman, H.; Ettenberg, S.A.; Katz, M.; Tsygankov, A.Y.; Alroy, I.; Lavi, S.; Iwai, K.; Reiss, Y.; Ciechanover, A.; et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 1999, 4, 1029–1040. [Google Scholar] [CrossRef]
  103. Uchiyama-Tanaka, Y.; Matsubara, H.; Mori, Y.; Kosaki, A.; Kishimoto, N.; Amano, K.; Higashiyama, S.; Iwasaka, T. Involvement of HB-EGF and EGF receptor transactivation in TGF-β-mediated fibronectin expression in mesangial cells. Kidney Int. 2002, 62, 799–808. [Google Scholar] [CrossRef] [PubMed]
  104. Iwabu, A.; Smith, K.; Allen, F.D.; Lauffenburger, D.A.; Wells, A. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase c delta-dependent pathway. J. Biol. Chem. 2004, 279, 14551–14560. [Google Scholar] [CrossRef] [PubMed]
  105. Tumur, Z.; Katebzadeh, S.; Guerra, C.; Bhushan, L.; Alkam, T.; Henson, B.S. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma. Neoplasia 2015, 17, 141–151. [Google Scholar] [CrossRef] [PubMed]
  106. Klemke, R.L.; Cai, S.; Giannini, A.L.; Gallagher, P.J.; de Lanerolle, P.; Cheresh, D.A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 1997, 137, 481–492. [Google Scholar] [CrossRef] [PubMed]
  107. Haase, I.; Evans, R.; Pofahl, R.; Watt, F.M. Regulation of keratinocyte shape, migration and wound epithelialization by IGF-1- and EGF-dependent signalling pathways. J. Cell Sci. 2003, 116, 3227–3238. [Google Scholar] [CrossRef] [PubMed]
  108. Jester, J.V.; Huang, J.; Barry-Lane, P.A.; Kao, W.W.; Petroll, W.M.; Cavanagh, H.D. Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Investig. Ophthalmol. Vis. Sci. 1999, 40, 1959–1967. [Google Scholar]
  109. Hinz, B.; Celetta, G.; Tomasek, J.J.; Gabbiani, G.; Chaponnier, C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 2001, 12, 2730–2741. [Google Scholar] [CrossRef] [PubMed]
  110. Tacke, F.; Gabele, E.; Bataille, F.; Schwabe, R.F.; Hellerbrand, C.; Klebl, F.; Straub, R.H.; Luedde, T.; Manns, M.P.; Trautwein, C.; et al. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig. Dis. Sci. 2007, 52, 3404–3415. [Google Scholar] [CrossRef] [PubMed]
  111. Pocsik, E.; Mihalik, R.; Ali-Osman, F.; Aggarwal, B.B. Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response. J. Cell Biochem. 1994, 54, 453–464. [Google Scholar] [CrossRef] [PubMed]
  112. Hamburger, A.W.; Mehta, D.; Pinnamaneni, G.; Chen, L.C.; Reid, Y. Density-dependent regulation of epidermal growth factor receptor expression. Pathobiology 1991, 59, 329–334. [Google Scholar] [CrossRef] [PubMed]
  113. Petridou, S.; Maltseva, O.; Spanakis, S.; Masur, S.K. TGF-β receptor expression and smad2 localization are cell density dependent in fibroblasts. Investig. Ophthalmol. Vis. Sci. 2000, 41, 89–95. [Google Scholar]
  114. Nakamura, K.; Kurosaka, D.; Yoshino, M.; Oshima, T.; Kurosaka, H. Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts. Investig. Ophthalmol. Vis. Sci. 2002, 43, 2603–2608. [Google Scholar]
  115. Meng, X.M.; Chung, A.C.; Lan, H.Y. Role of the TGF-β/BMP-7/Smad pathways in renal diseases. Clin. Sci. 2013, 124, 243–254. [Google Scholar] [CrossRef] [PubMed]
  116. Yasmin, N.; Bauer, T.; Modak, M.; Wagner, K.; Schuster, C.; Koffel, R.; Seyerl, M.; Stockl, J.; Elbe-Burger, A.; Graf, D.; et al. Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal langerhans cell differentiation. J. Exp. Med. 2013, 210, 2597–2610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Robertson, D.M.; Li, L.; Fisher, S.; Pearce, V.P.; Shay, J.W.; Wright, W.E.; Cavanagh, H.D.; Jester, J.V. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Investig. Ophthalmol. Vis. Sci. 2005, 46, 470–478. [Google Scholar] [CrossRef] [PubMed]
  118. Dean, C.; Ito, M.; Makarenkova, H.P.; Faber, S.C.; Lang, R.A. BMP7 regulates branching morphogenesis of the lacrimal gland by promoting mesenchymal proliferation and condensation. Development 2004, 131, 4155–4165. [Google Scholar] [CrossRef] [PubMed]
  119. Gao, B.; Zhou, X.; Zhou, X.; Pi, C.; Xu, R.; Wan, M.; Yang, J.; Zhou, Y.; Liu, C.; Sun, J.; et al. BMP7 and EREG contribute to the inductive potential of dental mesenchyme. Sci Rep. 2015, 5, 9903. [Google Scholar] [CrossRef] [PubMed]
  120. Ellman, M.B.; Kim, J.; An, H.S.; Chen, D.; Kc, R.; Li, X.; Xiao, G.; Yan, D.; Suh, J.; van Wjnen, A.J.; et al. Lactoferricin enhances BMP7-stimulated anabolic pathways in intervertebral disc cells. Gene 2013, 524, 282–291. [Google Scholar] [CrossRef] [PubMed]
  121. You, L.; Kruse, F.E. Differential effect of activin a and BMP-7 on myofibroblast differentiation and the role of the smad signaling pathway. Investig. Ophthalmol. Vis. Sci. 2002, 43, 72–81. [Google Scholar]
  122. Song, Q.H.; Singh, R.P.; Richardson, T.P.; Nugent, M.A.; Trinkaus-Randall, V. Transforming growth factor-beta1 expression in cultured corneal fibroblasts in response to injury. J. Cell Biochem. 2000, 77, 186–199. [Google Scholar] [CrossRef]
  123. Jester, J.V.; Barry-Lane, P.A.; Cavanagh, H.D.; Petroll, W.M. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea 1996, 15, 505–516. [Google Scholar] [CrossRef] [PubMed]
  124. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
  125. Gassmann, M.; Grenacher, B.; Rohde, B.; Vogel, J. Quantifying western blots: Pitfalls of densitometry. Electrophoresis 2009, 30, 1845–1855. [Google Scholar] [CrossRef] [PubMed]
Ijms 19 01415 g001 550
Figure 1. Relative expression levels of BMP7 mRNA in hTCEpi cells after treatment with SP (10−5 M) and NGF (100 ng/mL). Total RNA was isolated from SP and NGF treated hTCEpi cells after 24 h. Reverse transcription was performed using 1 µg of total RNA to prepare cDNA and qRT-PCR was performed to find differences in the expression levels of BMP7 mRNA. Relative expression pattern was analyzed by the comparative threshold cycle (2−ΔΔCt) method. Expression values were represented as fold change over the control on an arbitrary scale after normalization with GAPDH. Data represent mean ± standard deviation of three independent experiments. The p-values of <0.05 were considered statistically significant and are indicated by asterisks (*).
Figure 1. Relative expression levels of BMP7 mRNA in hTCEpi cells after treatment with SP (10−5 M) and NGF (100 ng/mL). Total RNA was isolated from SP and NGF treated hTCEpi cells after 24 h. Reverse transcription was performed using 1 µg of total RNA to prepare cDNA and qRT-PCR was performed to find differences in the expression levels of BMP7 mRNA. Relative expression pattern was analyzed by the comparative threshold cycle (2−ΔΔCt) method. Expression values were represented as fold change over the control on an arbitrary scale after normalization with GAPDH. Data represent mean ± standard deviation of three independent experiments. The p-values of <0.05 were considered statistically significant and are indicated by asterisks (*).
Ijms 19 01415 g001
Ijms 19 01415 g002 550
Figure 2. Hierarchal illustration of the differentially expressed genes in hTCEpi cells after treatment with BMP7 (100 ng/mL). Both twofold upregulated and downregulated genes were clustered. Untreated hTCEpi cells were served as control. After 24 h of treatment with BMP7, RNA was isolated and transcriptome-wide gene level expression profiling was performed using Clariom™ S arrays. Array scanning and data analysis were performed using Affymetrix® Expression Console™ software (v.1.4.1) that provides signal estimation and quality control functionality for the expression arrays, and the Affymetrix® Transcription Analysis Console (TAC) software (v.3.1), which performs statistical analysis and provides a list of differentially expressed genes. Expression level analysis was performed using the normalization method based on the processing algorithm called robust multi-array average (RMA) which was improved by Signal Space Transformation (SST-RMA, Affymetrix). Each array was performed in triplicates.
Figure 2. Hierarchal illustration of the differentially expressed genes in hTCEpi cells after treatment with BMP7 (100 ng/mL). Both twofold upregulated and downregulated genes were clustered. Untreated hTCEpi cells were served as control. After 24 h of treatment with BMP7, RNA was isolated and transcriptome-wide gene level expression profiling was performed using Clariom™ S arrays. Array scanning and data analysis were performed using Affymetrix® Expression Console™ software (v.1.4.1) that provides signal estimation and quality control functionality for the expression arrays, and the Affymetrix® Transcription Analysis Console (TAC) software (v.3.1), which performs statistical analysis and provides a list of differentially expressed genes. Expression level analysis was performed using the normalization method based on the processing algorithm called robust multi-array average (RMA) which was improved by Signal Space Transformation (SST-RMA, Affymetrix). Each array was performed in triplicates.
Ijms 19 01415 g002
Ijms 19 01415 g003 550
Figure 3. Validation of the Clariom™ S array identified differentially expressed transcripts. hTCEpi cells were cultured in the presence of 100 ng/mL BMP7 and RNA was isolated after 24 h. Reverse transcription was performed using 1 µg of total RNA to prepare cDNA and qRT-PCR was performed to find differentially expressed transcripts using respective primers. (A) ID proteins (ID1 and ID2); (B) cytoskeletal proteins (DSG4 and EPN3); and (C) metabolic enzymes (LOX, DUSP14, TGM5, CRYAB, and ATP1B1) differential expression was analyzed using respective primers. Relative expression pattern was analyzed by the comparative threshold cycle (2−ΔΔCt) method. Expression values were represented as fold change over the control on an arbitrary scale after normalization with GAPDH. Data represent mean ± standard deviation of three independent experiments. p-values of <0.05 were considered statistically significant and are indicated by asterisks (*).
Figure 3. Validation of the Clariom™ S array identified differentially expressed transcripts. hTCEpi cells were cultured in the presence of 100 ng/mL BMP7 and RNA was isolated after 24 h. Reverse transcription was performed using 1 µg of total RNA to prepare cDNA and qRT-PCR was performed to find differentially expressed transcripts using respective primers. (A) ID proteins (ID1 and ID2); (B) cytoskeletal proteins (DSG4 and EPN3); and (C) metabolic enzymes (LOX, DUSP14, TGM5, CRYAB, and ATP1B1) differential expression was analyzed using respective primers. Relative expression pattern was analyzed by the comparative threshold cycle (2−ΔΔCt) method. Expression values were represented as fold change over the control on an arbitrary scale after normalization with GAPDH. Data represent mean ± standard deviation of three independent experiments. p-values of <0.05 were considered statistically significant and are indicated by asterisks (*).
Ijms 19 01415 g003
Ijms 19 01415 g004 550
Figure 4. Wound healing scratch assay was made on 24 h growth factor-starved, confluent hTCEpi cells by scratching a line across the bottom of the culture dish. BMP7 was added (100 ng/mL) to the culture media and the cell motility and migration was observed at time points 10 and 24 h. The micrographs show the extent of scratch closure obtained under control conditions compared to those with the addition of BMP7. Cell migration quantification was evaluated by counting the number of cells in the central gap. Three independent experiments were performed and a representative result is shown. p-values of <0.05 were considered statistically significant and are indicated by asterisks (*).
Figure 4. Wound healing scratch assay was made on 24 h growth factor-starved, confluent hTCEpi cells by scratching a line across the bottom of the culture dish. BMP7 was added (100 ng/mL) to the culture media and the cell motility and migration was observed at time points 10 and 24 h. The micrographs show the extent of scratch closure obtained under control conditions compared to those with the addition of BMP7. Cell migration quantification was evaluated by counting the number of cells in the central gap. Three independent experiments were performed and a representative result is shown. p-values of <0.05 were considered statistically significant and are indicated by asterisks (*).
Ijms 19 01415 g004
Ijms 19 01415 g005 550
Figure 5. Protein tyrosine phosphorylation levels of (A) hTCEpi cells and (B) SFs after treatment with BMP7 (100 ng/mL) at different time points. Cells were treated with BMP7 and the total cell lysates were collected at time points 1, 5, 15, 30, 60 and 120 min, and subjected to immunoblot analysis. An increased total protein tyrosine phosphorylation (lasted until 30–60 min approximately) following BMP7 stimulation was evident. Amounts of the β-actin protein levels which were detected with an anti-β-actin antibody served as a loading control. One representative immunoblot of at least three independent experiments is shown.
Figure 5. Protein tyrosine phosphorylation levels of (A) hTCEpi cells and (B) SFs after treatment with BMP7 (100 ng/mL) at different time points. Cells were treated with BMP7 and the total cell lysates were collected at time points 1, 5, 15, 30, 60 and 120 min, and subjected to immunoblot analysis. An increased total protein tyrosine phosphorylation (lasted until 30–60 min approximately) following BMP7 stimulation was evident. Amounts of the β-actin protein levels which were detected with an anti-β-actin antibody served as a loading control. One representative immunoblot of at least three independent experiments is shown.
Ijms 19 01415 g005
Ijms 19 01415 g006 550
Figure 6. Activation of MAPK cascade proteins in (A) hTCEpi cells and (B) SFs after treatment with BMP7 (100 ng/mL) at different time points. Cells were treated with BMP7 and the total cell lysates were collected at time points 5 min, 30 min, 2, 6, 24 and 48 h after stimulation, and subjected to immunoblot analysis. Sustained activation of p44/42 MAPK and p38 until 48 h in hTCEpi cells and until 6 h in SFs was observed, whereas, in both cell types, only transient activation of pSAPK/JNK was observed. Amounts of the β-actin protein levels which were detected with an anti-β-actin antibody served as a loading control. Differences in the phosphorylation levels (p44/42 MAPK, SAPK/JNK and p38) were quantified using ImageJ software and the values were normalized to the corresponding β-actin signal. Data represent mean ± standard deviation of the phosphorylation levels shown as arbitrary units from more than three independent experiments. One representative immunoblot of at least three independent experiments is shown.
Figure 6. Activation of MAPK cascade proteins in (A) hTCEpi cells and (B) SFs after treatment with BMP7 (100 ng/mL) at different time points. Cells were treated with BMP7 and the total cell lysates were collected at time points 5 min, 30 min, 2, 6, 24 and 48 h after stimulation, and subjected to immunoblot analysis. Sustained activation of p44/42 MAPK and p38 until 48 h in hTCEpi cells and until 6 h in SFs was observed, whereas, in both cell types, only transient activation of pSAPK/JNK was observed. Amounts of the β-actin protein levels which were detected with an anti-β-actin antibody served as a loading control. Differences in the phosphorylation levels (p44/42 MAPK, SAPK/JNK and p38) were quantified using ImageJ software and the values were normalized to the corresponding β-actin signal. Data represent mean ± standard deviation of the phosphorylation levels shown as arbitrary units from more than three independent experiments. One representative immunoblot of at least three independent experiments is shown.
Ijms 19 01415 g006
Ijms 19 01415 g007 550
Figure 7. Activation of EMT-related signaling molecules in epithelial cells following the stimulation of BMP7 (100 ng/mL). Total protein lysates were collected at time points 5 min, 30 min, 2, 6, 24 and 48 h and subjected to immunoblot analysis. Differences in the phosphorylation levels (ERM and cofilin) and total protein levels (Zeb1 and claudin) was observed and quantified using ImageJ software and the values were normalized to the corresponding β-actin signal. Data represent mean ± standard deviation of the phosphorylation levels or total protein levels shown as arbitrary units from more than three independent experiments. One representative immunoblot of at least three independent experiments is shown.
Figure 7. Activation of EMT-related signaling molecules in epithelial cells following the stimulation of BMP7 (100 ng/mL). Total protein lysates were collected at time points 5 min, 30 min, 2, 6, 24 and 48 h and subjected to immunoblot analysis. Differences in the phosphorylation levels (ERM and cofilin) and total protein levels (Zeb1 and claudin) was observed and quantified using ImageJ software and the values were normalized to the corresponding β-actin signal. Data represent mean ± standard deviation of the phosphorylation levels or total protein levels shown as arbitrary units from more than three independent experiments. One representative immunoblot of at least three independent experiments is shown.
Ijms 19 01415 g007
Ijms 19 01415 g008 550
Figure 8. Immunofluorescence detection of the expression of α-SMA in primary human SFs after treatment with BMP7. Serum-starved SFs were cultured in the presence of BMP7 (100 ng/mL) and TGF-β1 (10 ng/mL) for 72 h and their activation was analyzed by staining with an anti-α-SMA (green) and vinculin (red) antibodies. An increase in the expression of focal adhesions was observed with vinculin antibody staining and the transformation of fibroblasts into activated myofibroblats was observed with α-SMA antibody staining. (B) (control), (E) (+BMP7) and (H) (+TGF-β1) represent α-SMA staining (green) and (C) (control), (F) (+BMP7) and (I) (+TGF-β1) represent vinculin (red) immune staining. (A,D,G) represent nuclei counter stained with 4,6-diamidino-2-phenylindole (DAPI) (blue). Scale bar: 50 μm.
Figure 8. Immunofluorescence detection of the expression of α-SMA in primary human SFs after treatment with BMP7. Serum-starved SFs were cultured in the presence of BMP7 (100 ng/mL) and TGF-β1 (10 ng/mL) for 72 h and their activation was analyzed by staining with an anti-α-SMA (green) and vinculin (red) antibodies. An increase in the expression of focal adhesions was observed with vinculin antibody staining and the transformation of fibroblasts into activated myofibroblats was observed with α-SMA antibody staining. (B) (control), (E) (+BMP7) and (H) (+TGF-β1) represent α-SMA staining (green) and (C) (control), (F) (+BMP7) and (I) (+TGF-β1) represent vinculin (red) immune staining. (A,D,G) represent nuclei counter stained with 4,6-diamidino-2-phenylindole (DAPI) (blue). Scale bar: 50 μm.
Ijms 19 01415 g008
Ijms 19 01415 g009 550
Figure 9. Activation of EGFR following BMP7 stimulation in (A) hTCEpi cells and (B) SFs. After BMP7 stimulation (100 ng/mL), total cell protein lysates were collected at time points 5 min, 30 min, 2, 6, 24, and 48 h and subjected to immunoblot analysis. Phosphorylation of EGFR at Tyr1045 and Tyr992 were analyzed using respective antibodies. Total EGFR protein levels were used to compare and calculate the differences in the phosphorylation levels. Differences in the phosphorylation levels (Tyr1045 and, Tyr992) were quantified using ImageJ software and the values were normalized to the corresponding total EGFR signal. Data represent mean ± standard deviation of the phosphorylation levels shown as arbitrary units from three independent experiments. One representative immunoblot of at least 3 independent experiments is shown.
Figure 9. Activation of EGFR following BMP7 stimulation in (A) hTCEpi cells and (B) SFs. After BMP7 stimulation (100 ng/mL), total cell protein lysates were collected at time points 5 min, 30 min, 2, 6, 24, and 48 h and subjected to immunoblot analysis. Phosphorylation of EGFR at Tyr1045 and Tyr992 were analyzed using respective antibodies. Total EGFR protein levels were used to compare and calculate the differences in the phosphorylation levels. Differences in the phosphorylation levels (Tyr1045 and, Tyr992) were quantified using ImageJ software and the values were normalized to the corresponding total EGFR signal. Data represent mean ± standard deviation of the phosphorylation levels shown as arbitrary units from three independent experiments. One representative immunoblot of at least 3 independent experiments is shown.
Ijms 19 01415 g009
Table
Table 1. Pathways significantly impacted during BMP7 stimulation in hTCEpi cells.
Table 1. Pathways significantly impacted during BMP7 stimulation in hTCEpi cells.
Pathway Namep-ValueKEGG
TGF-β signaling pathway5.780 × 10−5KEGG: 04350
Cell cycle2.556 × 10−4KEGG: 04110
Jak-STAT signaling pathway0.018KEGG: 04630
MAPK signaling pathway0.040KEGG: 04010
Osteoclast differentiation0.042KEGG: 04380
Significantly impacted pathways after BMP stimulation (p < 0.05) were arranged according to the p-value. KEGG = Kyoto Encyclopedia of Genes and Genomes. The GEP data were analyzed using Advaita Bio’s iPathwayGuide (http://www.advaitabio.com/ipathwayguide).
Table
Table 2. Biological processes significantly impacted during BMP7 stimulation in hTCEpi cells.
Table 2. Biological processes significantly impacted during BMP7 stimulation in hTCEpi cells.
Biological ProcessesDifferentially Expressed Genes/Total GenesGO Accessionp-Value
Mitotic cell cycle111/216GO: 00002784.000 × 10−9
Cell cycle149/321GO: 00070495.300 × 10−8
Cytoskeleton organization82/153GO: 00070105.500 × 10−8
Intermediate filament cytoskeleton organization10/10GO: 00451041.600 × 10−5
Regulation of cell cycle82/171GO: 00517262.300 × 10−5
Microtubule cytoskeleton organization42/73GO: 00002261.300 × 10−5
Intermediate filament organization8/8GO: 00451091.500× 10−4
Developmental process252/655GO: 00325023.100× 10−4
Tissue development100/234GO: 00098888.300 × 10−4
Negative regulation of protein phosphorylation26/46GO: 00019339.000 × 10−4
Cell proliferation111/272GO: 00082830.003
Epithelium development67/153GO: 00604290.003
TGF-β receptor signaling pathway11/16GO: 00071790.004
Inactivation of MAPK activity5/5GO: 00001880.004
Regulation of microtubule cytoskeleton organization13/21GO: 00705070.007
Positive regulation of Wnt signaling pathway12/19GO: 00301770.007
Positive regulation of cytoskeleton organization26/52GO: 00514930.009
MAPK cascade41/90GO: 00001650.009
Signal transduction by protein phosphorylation42/93GO: 00230140.010
Endothelial cell development4/4GO: 00018850.012
Desmosome organization4/4GO: 00029340.012
SMAD protein complex assembly4/4GO: 00071830.012
Osteoblast proliferation4/4GO: 00336870.012
Regulation of protein serine/threonine kinase activity31/66GO: 00719000.013
Cell surface receptor signaling pathway102/258GO: 00071660.014
Fibroblast proliferation10/16GO: 00481440.016
SMAD protein signal transduction5/6GO: 00603950.018
Regulation of actin polymerization or depolymerization8/12GO: 00080640.018
Regulation of phosphorylation68/166GO: 00423250.019
VEGF production7/10GO: 00105730.019
Interleukin-2 production7/10GO: 00326230.019
Cell adhesion79/197GO: 00071550.021
Epithelial cell differentiation41/94GO: 00308550.021
Response to BMP11/18GO: 00717720.024
Regulation of ROS metabolic process14/26GO: 20003770.024
Vesicle mediated transport51/122GO: 00161920.027
Chemokine production9/15GO: 00326020.030
Cell migration62/153GO: 00164770.031
Cellular response to TGF-β stimulus14/27GO: 00715600.035
Lipoxygenase pathway3/3GO: 00193720.037
Intermediate filament bundle assembly3/3GO: 00451100.037
Regulation of TGF-β receptor signaling pathway7/11GO: 00170150.038
Cell differentiation151/407GO: 00301540.039
Regulation of Interleukin-2 production6/9GO: 00326630.042
Response to growth factor34/79GO: 00708480.042
BMP signaling pathway10/18GO: 00305090.043
ATP generation from ADP5/7GO: 00067570.045
SMAD protein import to nucleus4/5GO: 00071840.045
Regulation of cyclin dependent protein kinase activity12/23GO: 19040290.047
Regeneration18/38GO: 00310990.049
Significantly impacted biological processes after BMP stimulation were arranged according to the p-value (p < 0.05). Differentially expressed genes in relation to the total number of genes in that process were denoted along with the gene ontology (GO) identifier. The GEP data was analyzed using Advaita Bio’s iPathwayGuide (http://www.advaitabio.com/ipathwayguide).
Table
Table 3. List of genes with most profound differential expression after BMP7 treatment.
Table 3. List of genes with most profound differential expression after BMP7 treatment.
Fold Change (Down Regulated)p-ValueGene SymbolFold Change (Up Regulated)p-ValueGene Symbol
−64.320.00018HIST1H3G8.050.000406ALOX12B
−58.470.000071TOP2A8.360.000067BAMBI
−46.840.000005ANLN8.370.000013ID2
−42.330.000046TFPI28.390.000018LCE3E
−41.850.000309HIST2H3A8.460.000245BDNF
−37.770.000009NCAPG8.490.000242DLX3
−36.570.000029CCNA28.510.000018FAM46B
−36.480.000107RRM28.540.00008CGB2
−34.740.000308HIST2H3A; HIST2H3C8.780.000024HK2
−29.490.00016TTK8.830.000403FPR3
−27.570.000001FAM111B8.840.00021BMP2
−25.327.63 × 10−7NUSAP190.000011CHRNA3
−24.30.000036PLK19.30.000094ULK3
−20.90.000371DLGAP59.580.000057DUSP1
−19.50.000003MKI679.60.000018GCOM1
−16.790.000208IL1B9.740.000781GABRA3
−16.570.000092CCNB29.740.000021SDR9C7
−16.550.000032ASPM9.740.000281RNF39
−16.270.000055KIF18A9.810.000849CYP4F22
−16.250.000072DTL9.920.00001DUSP14
−15.810.000586HIST1H1B10.180.000032MXD1
−15.570.00003GPR5010.340.00026ST3GAL4
−15.310.000043CENPF10.440.000002SPOPL
−15.230.000017SHCBP110.580.000063SLC7A8
−14.830.000305PBK10.670.00079LCE3C
−14.710.000777CKAP2L10.720.000034PSCA
−14.610.00001KIF20A10.890.000199DLX2
−14.20.000094LMNB111.020.000084LCE3D
−14.130.000024MELK11.170.000127PLBD1
−13.160.000482PRC112.560.000338KPRP
−12.650.000038DEPDC112.880.000074ATP1B1
−12.560.000045TACC313.240.000107CGB1
−12.530.000212HELLS13.680.000006EPN3
−12.450.000029NCAPG214.250.000003C10orf99
−12.250.000355BUB114.570.000011C5orf46
−12.060.000473CASC514.650.000002BPGM
−11.890.000104NDC114.840.000014GNA14
−11.810.000635FAM83D14.930.000294C1QTNF3-AMACR
−11.80.000488CCNE214.960.000013CGB5; CGB8
−11.430.000527KIF2314.970.000096SERPINB12
−11.170.000167CDC2015.660.000279MARCH3
−11.10.000901H2AFX16.073.57 × 10−7VSIG8
−10.970.000061KIF2C16.670.000159USP2
−10.770.000126STIL17.70.000147SLAMF9
−10.750.000582NCAPH18.030.000376SPAG17
−10.570.000444FOXM118.80.000024CGB8
−10.230.00036CCNB118.930.000319CLDN17
−10.090.000184TPX218.980.000083NPR3
−10.060.000045MCM519.80.000229CGB; CGB5
−9.910.000196XRCC219.940.000024LOX
−9.780.000011KIF14200.000026HPGD
−9.440.000053ARHGAP11A26.90.000814SPINK7
−9.40.000046DIAPH328.30.000024CRYAB
−9.260.000008MCM329.870.000029DIO2
−8.970.000141CDC637.640.000037ID1
−8.930.000088ARHGAP11B43.553.21 × 10−7DSG4
−8.730.000689SGOL156.480.000029SMAD6
−8.610.00009FANCA64.30.000012AMACR
−8.50.000047HJURP96.260.000007TGM5
−8.390.000032ADORA2B98.810.000061SPINK6
−8.010.000659TMEM97135.19.72 × 10−7FABP4
Genes with most profound differential expressions after BMP7 treatment compared to control in hTCEpi cells (Filters used: Anova p-value 0.001 and fold change 8 or −8, respectively).
Table
Table 4. List of primers used in the present study.
Table 4. List of primers used in the present study.
TargetPrimerPrimer Sequence (5’-3’)GenBank Accession
ATP1B1fwdTGAATTTAAGCCCACATATCAGGACCGNM_001677
revCATGTCATCCCTCTGGGCTGAATCT
CRYABfwdGGGAGATGTGATTGAGGTGCATGGNM_001289807
revAGGACCCCATCAGATGACAGGGAT
DSG4fwdGCAGCCTGTCGAGAAGGAGAGGACANM_001134453
revGTGATGTTAATTTCCCCAGTGCGAGG
EPN3fwdCTGCGCCTGAGCCGGCAGNM_017957
revTCAGGCTCTCTGTCCCGCTGATG
ID1fwdAACGGCGAGATCAGCGCCCTNM_002165
revTGTTCTCCCTCAGATCCGGCGA
BMP7fwdTCACAGCCACCAGCAACCACTGNM_001719
revACCATGAAGGGCTGCTTGTTCT
ID2fwdGCAGATCGCCCTGGACTCGCANM_002166
revCACCGCTTATTCAGCCACACAGTGC
LOXfwdTTACCCAGCCGACCAAGATATTCCTGNM_002317
revTTGTGGCCTTCAGCCACTCTCCTC
TGM5fwdAGGCTGGCAGGTGCTGGACGNM_004245
revCCTGGACGAGCCAGGACATGC
DUSP14fwdCAGCGCACACTGGACTCTTGAGGNM_007026
revGTCCTTGGTAGCGTGCTGTGACCT
GAPDHfwdGGATATTGTTGCCATCAATGACCCNM_002046
revTCTCGCTCCTGGAAGATGGTGA

Share and Cite

MDPI and ACS Style

Kowtharapu, B.S.; Prakasam, R.K.; Murín, R.; Koczan, D.; Stahnke, T.; Wree, A.; Jünemann, A.G.M.; Stachs, O. Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions. Int. J. Mol. Sci. 2018, 19, 1415. https://doi.org/10.3390/ijms19051415

AMA Style

Kowtharapu BS, Prakasam RK, Murín R, Koczan D, Stahnke T, Wree A, Jünemann AGM, Stachs O. Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions. International Journal of Molecular Sciences. 2018; 19(5):1415. https://doi.org/10.3390/ijms19051415

Chicago/Turabian Style

Kowtharapu, Bhavani S., Ruby Kala Prakasam, Radovan Murín, Dirk Koczan, Thomas Stahnke, Andreas Wree, Anselm G. M. Jünemann, and Oliver Stachs. 2018. "Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions" International Journal of Molecular Sciences 19, no. 5: 1415. https://doi.org/10.3390/ijms19051415

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop